<p>Raw264.7 cells were infected with WT bacteria for 8 h or 18 h, crosslinked, lysed, and sonicated for immunoprecipitation with anti-σ<sup>E</sup> Ab (sample) or anti-GFP Ab (control). After protein and RNA were removed, DNA was extracted as template for qPCR to determine the fold enrichment of the genomic binding loci of σ<sup>E</sup> in pulldowns with anti-σ<sup>E</sup> Ab versus anti-GFP Ab. The promoter 3 region of <i>rpoE</i> was used as positive control, and the promoter region of <i>hns</i> was chosen as negative control. Shown are the fold changes displayed in a logarithmic scale. The mean and S.D. values were obtained from independent biological triplicates.</p
<p>Chromatin Immunoprecipitation (ChIP) of ΔNp73 binding with SBE. The relative amount of ΔNp73 asso...
<p>(<b>8a</b>) Schematic diagram of the region around <i>URA3</i> with two flanking I-SceI sites. Ba...
<p><b>(A)</b> Venn diagram showing EBF1 and RBP-jκ occupancy sites specific to LCL (red) and Mutu I ...
<p><b>(A)</b> Targeted validation of σ<sup>54</sup> binding sites. ChIP-qPCR measurement of σ<sup>54...
<p>The substitutive consensus sequence consisted of nucleotides with the least prevalence at the cor...
<p>(A) Selected examples of ChIP-seq coverage of C/EBPα peaks in LSK cells. (B) ChIP-qPCR for IgG an...
(A) ChIP-Seq was performed using an anti-HA antibody to immunoprecipitate DNA prepared from iSLK HA-...
<p>After 1 hour of E2 treatment, C4–12/Flag.ERβ cells were subjected to ChIP assay using anti-Flag M...
<p>HepG2 cells cultured in the presence of 2 mM DTT for the indicated intervals were subjected to fE...
<p>A-C Bar histogram of qPCR analysis of amplified MS-KIF18A promoter in MCF-7 ChIPed by anti-ERα (A...
<p>(A) The number of EBNA 2 (green) and EBNA 3 (red) sequencing reads from immunoprecipitated Mutu I...
<p>(A) Representative results of qPCR experiments amplifying two separate regions of the <i>TLR4</i>...
<p>(A) EBNA 3 sequencing reads from immunoprecipitated Mutu III DNA plotted as in <a href="http://ww...
<p>(A) EBNA 2 (green) and EBNA 3 (red) sequencing reads from immunoprecipitated Mutu III DNA plotted...
qPCR validation of enrichment peaks identified by FUS and EWS ChIP-seq. The enrichment of DNA was qu...
<p>Chromatin Immunoprecipitation (ChIP) of ΔNp73 binding with SBE. The relative amount of ΔNp73 asso...
<p>(<b>8a</b>) Schematic diagram of the region around <i>URA3</i> with two flanking I-SceI sites. Ba...
<p><b>(A)</b> Venn diagram showing EBF1 and RBP-jκ occupancy sites specific to LCL (red) and Mutu I ...
<p><b>(A)</b> Targeted validation of σ<sup>54</sup> binding sites. ChIP-qPCR measurement of σ<sup>54...
<p>The substitutive consensus sequence consisted of nucleotides with the least prevalence at the cor...
<p>(A) Selected examples of ChIP-seq coverage of C/EBPα peaks in LSK cells. (B) ChIP-qPCR for IgG an...
(A) ChIP-Seq was performed using an anti-HA antibody to immunoprecipitate DNA prepared from iSLK HA-...
<p>After 1 hour of E2 treatment, C4–12/Flag.ERβ cells were subjected to ChIP assay using anti-Flag M...
<p>HepG2 cells cultured in the presence of 2 mM DTT for the indicated intervals were subjected to fE...
<p>A-C Bar histogram of qPCR analysis of amplified MS-KIF18A promoter in MCF-7 ChIPed by anti-ERα (A...
<p>(A) The number of EBNA 2 (green) and EBNA 3 (red) sequencing reads from immunoprecipitated Mutu I...
<p>(A) Representative results of qPCR experiments amplifying two separate regions of the <i>TLR4</i>...
<p>(A) EBNA 3 sequencing reads from immunoprecipitated Mutu III DNA plotted as in <a href="http://ww...
<p>(A) EBNA 2 (green) and EBNA 3 (red) sequencing reads from immunoprecipitated Mutu III DNA plotted...
qPCR validation of enrichment peaks identified by FUS and EWS ChIP-seq. The enrichment of DNA was qu...
<p>Chromatin Immunoprecipitation (ChIP) of ΔNp73 binding with SBE. The relative amount of ΔNp73 asso...
<p>(<b>8a</b>) Schematic diagram of the region around <i>URA3</i> with two flanking I-SceI sites. Ba...
<p><b>(A)</b> Venn diagram showing EBF1 and RBP-jκ occupancy sites specific to LCL (red) and Mutu I ...